Hutch News

Hutch News

Stories tagged 'clinical trials'

'Exciting' but early results in trial of immunotherapy for myeloma

Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease

Dec. 3, 2018 | by Susan Keown / Fred Hutch News Service

The patients were out of options to treat their advanced myelomas. Then, they enrolled on a new clinical trial of genetically reprogrammed immune cells called CAR T cells.

View story >


Revealing a new way that cancer can evade immunotherapy — and, maybe, how to stop it

How a new technology solved a mystery and honors one man’s legacy

Sept. 24, 2018 | by Susan Keown / Fred Hutch News Service

Before his aggressive cancer took his life, he donated his tissue samples to research. Now scientists think that new insights from his cells could save lives.

View story >


UCI-Fred Hutch collaboration turns 10

In Uganda, innovation and persistence allow a 'sustainable cancer program' to take root

June 12, 2018 | By Mary Engel / Fred Hutch News Service

In Uganda, innovation and persistence allow a "sustainable cancer program" to take root.

View story >


Fred Hutch at ASCO

Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering

June 5, 2018 | By Fred Hutch staff

Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering

View story >


What's new in prostate cancer: 5 takeaways

‘Many reasons for optimism’ says expert at annual community symposium

May 1, 2018 | by Susan Keown / Fred Hutch News Service

What's new in prostate cancer in 2018? The latest in prostate cancer treatment, screening, survivorship and more.

View story >


Early phase clinical trial shows promise for advanced head and neck cancer

Nine out of 10 patients treated with the experimental therapy saw their tumors shrink

April 13, 2018 | By Rachel Tompa / Fred Hutch News Service

When you look at Carla Stone, you might not guess that she was diagnosed with stage 4 head and neck cancer just two years ago. Stone participated in a clinical trial that shrank her advanced tumor down to nothing, allowing her to undergo a minimally invasive surgery.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.